Newsroom | NeoGenomics Laboratories

November 1, 2022

Case Study: How Pharma Uses NeoGenomics Real-World Oncology Data to Accelerate Biomarker Adoption and Commercial Launch

Blog

November 1, 2022

The Breakroom Video Series

Blog

October 28, 2022

NeoGenomics Provides Update on MolDX Submission for CRC and RaDaR(TM) Commercial Launch

Press Release

October 28, 2022

Taking Spatial Toward the Clinic: DeciBio’s Q&A with Sandy Au of NeoGenomics

Blog

October 25, 2022

Is IHC going to exhaust our archival blocks the way single gene testing used to?

Blog

October 19, 2022

NeoGenomics announces speaker program, ‘Minimal Residual Disease in Colorectal Cancer’

Blog

October 13, 2022

NeoGenomics Schedules its Third Quarter 2022 Earnings Release for November 8, 2022

Press Release

October 4, 2022

IVDR at NeoGenomics

Blog

Fact Sheets

Company Overview

Diagnostic Services

Pharma Services

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients